Trial of Pevonedistat Plus Docetaxel in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer
Status:
Unknown status
Trial end date:
2021-03-01
Target enrollment:
Participant gender:
Summary
This study is a single institution Phase II single arm trial to assess the efficacy of the
combination of pevonedistat plus docetaxel in patients with previously treated advanced NSCLC
(non-small cell lung cancer).
Phase:
Phase 2
Details
Lead Sponsor:
University of Michigan Cancer Center University of Michigan Rogel Cancer Center